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Summary
Pathogenetic studies of herpes simplex virus type 1 (HSV1) strains ANG and its mouse brain-
passaged descendant ANG path revealed no difference in neurovirulence but a significant difference
in neuroinvasiveness. Thus, both viruses induced a fatal encephalitis in mice afterdirect injection
into the brain, but only ANG path induced lethal neurologic disease after inoculation on rear
footpads. The difference in neuroinvasiveness is not related to the capacity to replicate in mouse
neural tissues or mouse cells in general, but is specifically related to virus entry into the peripheral
nervous system in the footpad. Marker rescue experiments in which ANG path genes were used
to confer neuroinvasiveness on ANG indicated that the gene that codesfor glycoprotein D (gD)
is responsible for the phenotypic difference. Analyses of the gD genes by dideoxy-sequencing
techniques identified a base difference in the coding sequences and predicted that the ANG gD
gene codes for alanine (GCC codon) at amino acid position 84 in the open reading frame and
the ANG path gD gene codes for glycine (GGC codon) at this site. Using these data, an
oligonucleotide probe predicted to be specific for the ANG path gD gene was prepared, and
in Southern blot analyses, this proberevealed that neuroinvasiveness-rescued agents had incorporated
the base change seen in the ANG path gD gene. We conclude that HSV1 glycoprotein D functions
to effect neuroinvasiveness and we discuss potential mechanisms that may be involved.
A
definition of the specific interactions that take place be-
tween viruses and target organs is a critical goal in un-
derstanding viral pathogenesis. Powerful approaches employed
in this area are those designed to identify and functionally
characterize viral genes and gene products that are required
for infection and replication in unique differentiated cell types
in these organs (1, 2). A target organ that has received con-
siderable attention from virologists is the brain, and HSV is
an agent that has well-appreciated but incompletely under-
stood interactions with both the brain and the peripheral
nervous system (3). To understand the pathogenesis of HSV
infections as they relate to the nervous system, three phases
of the process must be understood. Thus, the mechanisms
by which HSV (a) gains access to the nervous system (neu-
roinvasiveness), (b) causes disease in the central nervous system
(neurovirulence), and (c) is maintained for extended periods
in a nonreplicating form in neurons (latency) require defini-
tion. The focus of this investigation is identification and char-
acterization of HSV genes that specifically effect neuroinva-
siveness.
We show that HSV1 strain ANG (4, 5) demonstrates a
phenotype specifically reduced for neuroinvasiveness. Thus,
in contrast to most HSV strains, ANG is completely non-
lethal for mice when inoculated on rear footpads, but it is
fully neurovirulent when injected directly into the brain. By
comparison, a brain-passaged derivativeofANG named ANG
path (4, 5) causes lethal neurologic disease afterboth footpad
inoculation (it is now neuroinvasive) and direct injection into
the brain. The basis of this biologic difference is not related
to the capacity to replicate in mouse neural tissues or mouse
cells in general. Rather, tracing studies of virus infection
in the mouse indicate that the difference is specifically related
to the ability of the neuroinvasive ANG path agent to enter
the peripheral nervous system in the footpad. Marker rescue
experiments employing ANG path genes to confer neuroin-
vasiveness on ANG indicate that the gene that codes for gly-
coprotein D (gD)l is responsible for this difference. To es-
tablish unequivocally that gD is involved, the gD genes from
both agents were sequenced, and a single base difference was
identified. Analysis of the gD gene sequences predicts that
the ANG gD gene codes for an alanine at position 84 in the
mature protein, and the ANG path gD gene codes for a gly-
cine at this position. Using these data, an oligonucleotide
1 Abbreviations used in this paper. gD, glycoprotein D; MEF, mouse
embryo fibroblasts.
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dures to show that neuroinvasive agents derived by marker
rescue encode the same base change seen in the ANG path
gD gene.
Materials and Methods
VirusStrainsandTissue Culture.
￿
HSV1 strainsANGandANG
path have been describedpreviously (4, 5). Theprocedures fortissue
culture of rabbit skin cells, preparation ofprimary mouse embryo
fibroblasts, and infection, propagation, titration and plaque pu-
rification of viruses were described previously (6, 7).
Mouse Inoculations and Virulence Testing.
￿
Outbred, 4-week old
male Swiss-Webster mice (SimonsenLaboratories, Gilroy, CA and
Harlan SpragueDawley, Indianapolis, IN) were used, and equiva-
lent results were obtained with mice from thetwo suppliers. Stan-
dard methods forintracranial inoculation (6, 7), scarifiedrear footpad
inoculation with andwithout saline pre-treatment (8), and quan-
titation of virulence were used (9).
DNA CloningandAnalysis.
￿
Methods forDNAcloning, trans-
formation, propagation and storage of bacteria, and mini-prep-
arations ofplasmidDNAhave been described(10). Restriction en-
zymes BamHI, BgIII, ClaI, EcoRl, HindIII, Hpal, NarI, Ncol,
NruI,PstI, PvuII, Sall, Smal, and XbaI (BethesdaResearch labora-
tories, Gaithersburg, MD); Asp718 and Nael (Boehringer Mann-
heim Biochemicals, Indianapolis,IN); AatII, AccI, andKpnI (New
EnglandBiolabs, Beverly, MA); and Ddel, Sacl, and SacII (Stra-
tagene, La Jolla, CA) were used according to manufacturer's
directions.
Transfection and In Vivo Selection ofRecombinants.
￿
The method
forisolating virion and cloned DNAfor transfection by isopycnic
centrifugation has been described (11). ANG was marker rescued
by calcium phosphate transfection of rabbit skin cells with ANG
DNA andacloned DNAfragment as described previously, except
that neuroinvasive recombinants were selected by inoculating virus
onto saline-pretreated rear feet ofmice and recovering virus from
the brains of killed mice (6, 7, 12, 13).
DNA Sequencing.
￿
Sanger dideoxy DNA sequencing was per-
formed usingSequenasev2.0 (US. Biochemical Corp., Cleveland,
OH) according to the manufacturer's directions with [35S]dATP
(Amersham Corp., ArlingtonHeights, IL). Gelelectrophoresisand
autoradiography have been described previously (10).
OligonucleotidePrimers andEnd-labeling.
￿
Ohgonucleotide primers
were prepared by Dr.Dohn Glitz, Department ofBiological Chem-
istry, UCLA. Primers were purified on a20% acrylamide sequencing
gelusingpublishedmethods. Standard procedures for5' end-labeling
resulted in specific activities greater than 5 x 108 cpm/p,g (10).
Southern BlotAnalyses.
￿
Preparation ofviral DNA foranalytical
purposes has been described(12), andstandard methods foragarose
gel electrophoresis were used. Procedures forSouthern blotting, hy-
bridization andautoradiographyhave been describedpreviously (10).
Results
HSVI ANGandANG Path Differ Specifically in Neuroin-
vasiveness. Comparativeneuroinvasiveness ofthe two agents
wasestablished by inoculating virus on scarified rear footpads
of mice and scoring for death resulting from encephalomye-
litis. As shown in Table 1, ANG path is lethal and demon-
strates a median lethal dosage (LDso) of -105 PFU. In con-
trast, ANG is completely non-lethal for mice even when
inoculated with as much as 108 PFU, the highest dosage of
Table 1. Median Lethal Dosages (PFU/LD5o) ofHS-1 ANG
and ANG Path after Intracranial or Rear Footpad Inoculation
Mice were inoculated with serial decimal dilutions of virus stock by
the route indicated, and deaths from encephalomyelitis were scored
over a period of 21 d after inoculation. PFU/LD50 ratios were calcu-
lated as described in Materials and Methods.
virus we could obtain, so we were unable to calculate an
LD5O. Following virus inoculation directly into the brain,
ANG and ANG path are similarly neurovirulent and dem-
onstrate LDsos of about 1 PFU. This result indicates that
ANG's inability to kill mice after footpad inoculation cannot
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Hours
Figure 1.
￿
Replication cycles of HSV1 strains ANG and ANG path
in primary mouse embryo fibroblasts maintained at 38.5°C. 106 cells
were infected at a multiplicity of 0.001 PFU/cell. At the times indi-
cated, three samples were frozen at -70°C. When all samples were
accumulated, samples were thawed and frozen twice before they were
titrated for virus. ANG (0), ANG path (A).
Virus
Intracranial
inoculation
Footpad
inoculation
ANG 0.2 >1 .9 x 10,
ANG path 0.1 7.2 x 105be attributed to a generalized lack ofvirulence for the nervous
system.
To further establish that the biologic difference is specific
for neuroinvasiveness, virus replication was studied in mouse
embryo fibroblasts (MEF) maintained in tissue culture at
38.5°C, the normal body temperature for mice. A low mul-
tiplicity of infection (0.001 PFU/cell) was used to approxi-
mate more closely infection in vivo. As seen in Fig. 1, ANG
and ANG path demonstrate similar replication profiles. As
an extension ofthis experiment, virus replication in vivo fol-
lowing direct injection of 100 PFU into mouse brains was
also studied. As shown in Fig. 2, ANG and ANG path repli-
cate to similar levels in the mouse brain through 84 h. After
84 h, all mice are dead. These results indicate that ANG is
not restricted for replication in mouse neural tissues in vivo
and, when taken with those obtained in vitro, show that
ANG's inability to kill after footpad inoculation is not at-
tributable to a general defect for replication in mouse cells.
Anatomic Site ofRestriction ofANG Neuroinvasiveness.
￿
To
determine where in the neural route from the footpad to brain
106
108
m
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Hours
Figure 2.
￿
Replication cycles of HSV1 strains ANG and ANG path
in mouse brains in vivo. 100 PFU in 0.03 ml were injected into the
left cerebral hemisphere. At the times indicated, three mice per virus
were killed, and their brains were removed and frozen at -70°C.
When all samples were collected, brains were homogenized as 10%
(wt/vol) suspensions and centrifuged 5 min at 3,000 g. The resulting
supernatant was titrated for virus. ANG ((]), ANG path (0).
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the ANG invasion is restricted, we inoculated mice with 106
PFU on scarified rear footpads. Feet, sciatic nerves, lumbosacxal
spinal ganglia, dorsal roots, spinal cords, and brains were re-
moved at various intervals afterinoculation, and these tissues
were titrated for virus content. In the footpad (Fig. 3 A),
ANG is somewhat restricted for replication compared with
ANG path. In the nervous tissues that were examined (Fig.
3, B-F), ANG demonstrates restrictedreplication compared
with ANG path, the difference between the replication of
ANG and ANG path is more pronounced in more central
nervous tissues, and no ANG is detected in the brain. These
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Figure 3.
￿
HSV in tissues along the neural route of infection from
the footpad to the brain. Mice were inoculated on scarified rear
footpads with 106 PFU of virus. On the days indicated, three mice
were killed, feet (A), sciatic nerves (B), lumbosacral spinal ganglia
(C), dorsal roots (D), spinal cords (E), and brains (F) were removed,
and all tissues were frozen at -70°C. Once all samples were accu-
mulated, tissues were homogenized as 10% (wt/vol) suspensions and
centrifuged 5 min at 3,000g. The resulting supernatant was titrated
for virus. ANG (p), ANG path (A). Dashed line indicates limit of
assay sensitivity.results indicate that the ANG invasion is restricted in the
footpad, and this restriction may lead to reduced amounts
of ANG in neural tissues.
Although the resultsjust presented indicated that the ANG
invasion is restricted in the footpad, the exact nature of the
neuroinvasiveness defect might be related to restricted repli-
cation in some cell type unique to the footpad or it could
be due to reduced entry into the nervous system in the footpad.
To investigate this further, we inoculated mice on rear footpads
with 108 PFU of ANG and 106 PFU of ANG path and as-
sessed virus invasion into the nervous system. In the footpad
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Figure 4.
￿
HSV in tissues along the neural route of infection from
the footpad to the brain after rear footpad inoculation with 108 PFU
of ANG and 106 PFU of ANG path. On the days indicated, three
mice were killed, feet (A), sciatic nerves (B), lumbosacral spinal gan-
glia (G), dorsal roots (D), spinal cords (E), and brains (F) were re-
moved, and all tissues were frozen at -70°C. Once all samples were
accumulated, tissues were homogenized as 10% (wt/vol) suspensions
and centrifuged 5 min at 3,000 g. The resulting supernatant was
titrated for virus. ANG (Q), ANG path (A). Dashed line indicates
limit of assay sensitivity.
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(Fig. 4 A), there is more ANG than ANG path until day
3, at which time both agents reach 4 x 10° PFU/foot. On
days 4 and 5, there is more ANG path than ANG, and by
day 9 neither virus is recovered in the footpad. Clearly, the
cumulative amounts of ANG and ANG path in the footpad
are similar. And there is more ANG in the footpad during
the first 3 d of infection. Nevertheless, in the nervous tissues
that were examined (Fig. 4, B-E), ANG demonstrates re-
stricted replication compared with ANGpath, the difference
between the replication of ANG and ANG path is more pro-
nounced in more central nervous tissues, and no ANG is de-
tected in the brain. From these results, we conclude that a
defect in ANG leads to reduced virus entry into the nervous
system in the footpad. In addition, there may be a restriction
related to entry into the central nervous system.
Identification of the Genetic Defect in ANG.
￿
The general
strategy of marker rescue has been described previously (7,
13). In brief, ANG DNA is transfected into cells with cloned
genes from ANG path. Virus recombinants are generated and
analyzed by inoculation on mouse rear footpads. If at least
one mouse out of a group offour is killed, the co-transfection
culture is scored positive and is presumed to contain neu-
roinvasive recombinant agents. Initially, cloned XbaI and
EcoRI fragments spanning the entire HSV genome were used,
and the results (data not shown) indicated that the ANG path
EcoRI h fragment (0.867-0.963 map units) conferred neu-
roinvasiveness on ANG. Virus from cell cultures transfected
with ANG DNA and its own EcoRI h fragment never killed
mice.
Viruses recovered from the brains of mice killed by infec-
tion with ANG path EcoRI h and ANG DNA co-transfection
cultures were plaque-purified and analyzed for neuroinvasive-
ness. As shown in Table 2, these agents (SAP130 3.1, 6 12
6.1, 8 12 C4, and 9 8 A2) demonstrate LDsos of ti106 PFU,
ANG path was N10 times more lethal (LDso of N105 PFU),
and ANG was at least 100 times less lethal (LDso > 108
PFU). To demonstrate that these results were not attributable
Table 2.
￿
Median Lethal Dosages (PFU/LDso) ofHSV-1
ANG, ANG Path, and ANG Path $coRl h Rescued Viruses
after Rear Footpad Inoculation
Mice were inoculated with serial decimal dilutions of virus stock on
scarified rear footpads, and deaths from encephalomyelitis were
scored over a period of 21 d after inoculation. PFU/LDso ratios
were calculated as described in Materials and Methods.
Virus Exp. 1 Exp. 2
ANG >6 .1 x 10' >6.5 x 10'
ANG path 2.4 x 105 1.1 x 105
5AP130 3.1 1.8 x 10,
6126.1 1.6x108 7.1x1()6
812 C4 4.4x106 5.6x106
98A2 1.5x106 1.5x106to transfection-induced artifact (14), we carefully tested the
genetic stability ofANG. Mouse footpads were injected sub-
cutaneously with 10% (wt/vol) sodium chloride, a proce-
dure that enhances susceptibility to infection (15), before they
were inoculated with virus generated by ANG DNA co-
trinsfection with its own EcoRI h fragment . On day 6, the
approximate day mice inoculated with virus generated byANG
path EcoRI h DNA andANG DNA co-transfections had
died, mice were killed . 16 separate viruses were recovered from
brains, stocks were made in cell culture, and viruses were
analyzed by inoculating 108 PFU on rear footpads . None of
these virus isolates induced a lethal infection . These results
indicate that the neuroinvasiveness defect in ANG is not al-
tered by transfection per se but by the genes included in the
transfection .
We next attempted to precisely localize the defect inANG
with subclones of theANG path EcoRI h fragment . EcoRI
hDNA was subcloned into three pieces, KpnI f (the middle
fragment) and EcoRI h del f (the end fragments), and these
were used in marker rescue experiments. The results (Fig.
5) indicate that the KpnI f fragment rescues ANG for neu-
roinvasiveness. Although the EcoRI h del f fragment gave
a positive result in one experiment,we were unable to repeat
this, and we attribute this one individual result to a group
of mice that was uniquely susceptible to infection (the KpnI
f fragment was positive in seven of nine of the cultures tested
in this experiment) .
The ANG path KpnI f fragment was then divided into
smaller fragments, KpnI f/HindIII n, BamHI j, and KpnI
f/HindIII g. In three experiments (Fig. 6), the BamHIj frag-
ment and the KpnI f/HindIII g fragment conferred neuroin-
vasiveness on ANG, so attention was focused on the three
open reading frames (ORFs) that are encoded in the region
Figure 5 .
￿
Rescue of HSV1 ANG neuroinvasiveness using subclones
of the ANG path EcoRl h DNA fragment . Cloned ANG path genes
were transfected into cells with ANG DNA . The progeny virus was
tested by inoculation on rear footpads of mice. Fractions indicate the
number of co-transfection cultures that killed mice divided by the
total number of cultures tested. As shown, ANG path KpnI f (*)
consistently conferred neuroinvasiveness on ANG. The top line
represents the HSV genome. (M) Long segment inverted repeats;
(0) short segment inverted repeats. Beneath this, the EcoRl h, the
KpnI f, and the EcoPU h del f fragments are expanded from their
physical location in the genome.
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Figure 6 .
￿
Rescue ofHSV1 ANG neuroinvasiveness using subclones
of the ANG path KpnI f DNA fragment. Cloned ANG path genes
were transfected into cells with ANG DNA . The progeny virus was
tested by inoculation on rear footpads of mice . Fractions indicate the
number of co-transfection cultures that killed mice divided by the total
number of cultures tested . As shown, ANG path BamHI j (*) and
HindIII g/KpnI f (+) conferred neuroinvasiveness on ANG. The top
line represents the HSV genome. (m) Long segment inverted repeats ;
(M) short segment inverted repeats . Beneath' this, the KpnI f, the
KpnI f/HindIII n, the BamHI j, and the HindIII g/KpnI f fragments
are expanded from their physical locations in the genomes .
Figure 7 .
￿
Rescue of HSV1 ANG neuroinvasiveness using clones of
the ANG path genes that comprise gD, gI, and gE. Cloned ANG
path restriction fragments were transfected into cells with ANG
DNA. The progeny virus was tested by inoculation on rear footpads
of mice. Fractions indicate the number of co-transfection cultures that
killed mice divided by the total number of cultures tested . As shown,
ANG path HindIII/SacI 2 .4 (*) and HindIII/NruI 1.4 (+) conferred
neuroinvasiveness on ANG . The top line represents the HSV genome.
(M) Long segment inverted repeats, (M) short segment inverted
repeats. Beneath this, the HindIII/SacI 2 .4, the HindIII/NruI 1.4,
Nael/Ddel 1.6, and the DdeI/SalI 2 .1 fragments are expanded from
their physical locations in the genome. Also shown in relation to these
fragments are the US5, US6/gD, US7/gl and the US8/gE transcripts
(-) and open reading frames (O) .shared by theBamHIj and KpnI f/HindIII g fragments. Those
three ORFs code for glycoprotein D or US6, glycoprotein
I or US7, and glycoproteinE orUS8 . A 2.4-kb HindIII-SacI
fragment comprising theORFs for glycoproteinD (gD) and
glycoprotein I (gl), a 1.6-kb NaeI-DdeI clone encompassing
the gl ORF, and a 2.1-kb DdeI-Sall fragment spanning the
ORF for glycoprotein E (gE) were used in marker rescue
experiments . As shown in Fig. 7, the HindIII-SacI fragment
comprising the gD and gI ORFs and the DdeI-Sall fragment
encoding thegE ORF conferred neuroinvasiveness on ANG.
Since the fragment that spans the ORFs for both gD and
gl but not the 1.6-kb NaeI-DdeI clone encompassing the gI
ORF was positive, the gD ORF was implicated as a gene
responsible for the neuroinvasiveness defect inANG. To ex-
amine this, marker rescue experiments using a 1.4-kb HindIII-
NruI fragment that encompasses the gD ORF were per-
formed . As shown in Fig. 7, the ANG path HindIII-NruI
fragment rescuedANG for neuroinvasiveness. Here, we were
not able to repeat the positive result obtained earlier with
the 2.1-kb DdeI-SaII fragment that spans the ORF for gE
and have not pursued this aspect further.
The ANG path 1.4-kb HindIII-NruI fragment was com-
pared with the homologous ANG fragment and, as summa-
rized in Fig. 8, the ANG path but not the ANG clone con-
ferred neuroinvasiveness onANG . These data implicated the
gD gene with the neuroinvasiveness defect in ANG, but it
was still possible that sequences that encode the promoter
Figure 8 .
￿
Rescue of HSV1 ANG neuroinvasiveness using clones of
the ANG and ANG path genes that comprise gD. Cloned restriction
fragments were transfected into cells with ANG DNA . The progeny
virus was tested by inoculation on rear footpads of mice. Fractions in-
dicate the number of co-transfection cultures that killed mice divided
by the total number of cultures tested. ANG path HindIII/NruI 1.4
and ANG path HindIII/NarI 1.0 conferred neuroinvasiveness on ANG.
The top line represents the HSV genome. (M) Long segment in-
verted repeats, (0 ) short segment inverted repeats. Beneath this, the
HindIII/NruI 1 .4 and the HindIII/NarI 1.0 fragments are expanded
from their physical location in the genome . Also shown in relation to
these fragments are the US5, US6/gD, and US7/gl transcripts (-) and
open reading frames (O) .
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Table 3.
￿
Rescue of HSV-1 ANG Neuroinvasiveness using
DNA Clones of theANG Path and the ANG gD Gene
Attached to theANG HindIII n DNA Fragment
The ANG and the ANG path HinMI-NarI fragments (0.914-0.921
Map units) which code for most of gD were ligated to the ANG
HindIII n DNA fragment (0.878-0.914 map units) to generate
DNA clones that span the region from 0.878 to 0.921 map units .
Cloned DNA constructs were transfected into cells with ANG
DNA . The progeny virus was tested by inoculation on rear footpads
of mice . Fractions indicate the number of co-transfection cultures
that killed mice divided by the total number of cultures tested . As
shown, the ANG path gD + ANG HindIII n fragment conferred
neuroinvasiveness on ANG.
oftranscription for the gI gene were responsible . To examine
this possibility, -400 by were removed from one end of the
1.4-kb HindIII-NruI fragments by cleavage with NarI . The
resulting 1.0-kb HindIIl-NarI fragments span -80% of the
gD open reading frame and stop -340 by upstream of the
5' end of the gI transcript . As seen in Fig. 8, theANG path
HindIII-NarI fragment but not theANG clone rescuedANG
for neuroinvasiveness . As the cumulative data indicate, de-
creasing'the length ofDNA fragments employed decreases
the relative ratio of positive transfections . A likely reason for
this result is the decreased efficiency of recombination which
is known to take place for markers present in shorterDNA
fragments . To determine whether this was the case, we at-
tempted to enhance rescue of the neuroinvasiveness defect in
ANG by ligating a 5.6-kb ANG HindIII n fragment (0.878-
0.914map units) to the 1.0-kb ANG path HindIII-NarI frag-
ment (0.914-0.921 map units) . As shown in Table 3, three
of six and two of six cultures generated by co-transfecting
the expandedANG pathgD clone with ANGDNA rescued
ANG for neuroinvasiveness. As Table 3 also indicates, a simi-
larly expandedANG HindlII n plusANG HindIII-NarI frag-
ment did not kill mice (zero o£ six and zero of six cultures
were positive) . Clearly, this maneuver restores the efficiency
of rescue of ANG neuroinvasiveness to a level (42%) com-
parable to the 37% obtained with the similarly sized ANG
path HindIII g/KpnI f fragment described earlier (Fig. 6) .
Based upon this and the other marker resuce analyses de-
scribed, we conclude that a significant defect in the virus
ANG which restricts neuroinvasiveness maps within the 1.0
kb HindIII-NarI fragment which codes for most of the open
reading frame of glycoprotein D .
Site ofDefect in theANGgD Gene.
￿
To determine where
in the gene which codes forgD the alteration occurred, two
approaches were taken . First, theANG and ANG path gD
genes were sequenced . Second, viral isolates recovered from
the brains of mice that were killed by infection in marker
rescue experiments were analyzed both phenotypically and
Cloned fragment Exp . A Exp . B
ANG path gD + ANG HindIII n
ANG gD + ANG HindIII n
3/6
0/6
2/6
0/6Hhdg
AAG CTT GAG CQT' GAA CGA CCA ACT ACC OW ATC ATC AGT TAT OCT
TAA GGT CTC TTT TGT GM GM CGT TOO GGT I ATO~
GL
GOG
Y ALA
Sipnel Sequence
ALA ARG LEU GLY ALA VAL ILE LEU PHE VAL VAL ILE VAL GLY LEU
ATT TTG TTT GTC OTC ATA GM GGI; TC
1
￿
10
HIS
￿
GLY VAL ARG
(25)
I LYS TYR ALA LEU ALA ASP ALA SER LEU LYS
CAT OOG GTC OW GOC AAA TAT OGG TTG GCG GAT GOC TCT CTC AAG
25
MET ALA ASP PRO ASN CGC PHE ARG GLY LYS ASP LEU PRO VAL PRO
ATG GOC GAC CCC AAT OW TTT CGC GOO AAA GAC CTT COG GTC CCG
40
ASP ARG LEU THR ASP PRO PRO GLY VAL ARG ARG VAL TRY HIS ATC
GAC COG CTG ACC GAC OCT COG G3G GTC COO GGC GM TAC CAC ATC
55
GLN ALA GLY LEU PRO ASP PRO PHE GLN PRO PRO SER LEU PRO ILE
CAG GCG GGC CTA COG GAC GCG TTC CAG CCC CCC AGC CTC COG ATC
70
THR VAL TYR TYR ALA VAL LEU GLU ARG ALA CYS ARG SER VAL LEU
ACG GTT TAC TAC GOC GTG TTG GAG CSC GOC TGC CGC AGO GTG CTC
85
LEU ASN ALA PRO SER GLU ALA PRO GLN ILE VAL ARG GLY GLY SER
CTA AAC GCA COG TOG GAG GOC CGC CAG ATT GTC CGC GG3 GOC TCC
ALA 100
GLU ASP VAL ARG LYS GLN PRO TYR ASN LEU THR ILE ALA TRP PHE
GAA GAC GM COG AAA CAA CGC TAC AAC CTC ACC ATC GCT TGG TTT
115
ARG MET GLY GLY ASN CYS ALA ILE PRO ILE THR VAL MET GLU TYR
03G ATG GOA GGC AAC TGT GCT ATC CCC ATC ACG GTC ATG GAG TAC
130
THR GLU CYS SER TYR ASN LYS SER LEU GLY ALA CYS PRO ILE ARG
ACC GAA TOC TOC TAC AAC AAG TCT CTG G33 OCC TGT CGC ATC CGA
145
THR GLN PRO ARG TRP ASN TYR TYR ASP SER PHE SER ALA VAL SER
ACG CAG CCC OGC TOG AAC TAC TAT GAC AGC TTC AGC OCC GTC AGC
160
GLU ASP ASN LEU GLY PHE LEU MET HIS ALA PRO ALA PHE GLU THR
GAG GAT AAC CTG G33 TTC CTG ATG CAC GOC CCC GCG TTT GAG ACC
175
ALA GLY THR TYR LEU ARG LEU VAL LYS ILE ASN ASP TAP THR GLU
GOC GGC ACG TAC CTG CGG CTC GTG AAG ATA AAC GAC TGG ACG GAG
190
ILE THR GLN PHE ILE LEU GLU HIS ARG ALA LYS GLY SER CYS LYS
ATT ACA CAG TTT ATC CTG GAG CAC CGA GOC AAG GGC TCC TGT AAG
205
TYR ALA LEU PRO LEU ARG ILE PRO PRO SER ALA CYS LEU SER PRO
TAC GOC CTC COG CTG CGC ATC CCC COG TCA GOC TGC CTC TCC OCC
220
GLN ALA TYR GLN GLN GLY VAL THR VAL ASP SER ILE GLY MET LEU
CAG GOC TAC CAG CAG G33 GTG ACG GTG OAC AGC ATC GOG ATG CTG
235
PRO ARG PHE ILE PRO GLU ASN CAG ARG ILE VAL ALA VAL TYR SER
CCC CGC TTC ATC CCC GAG AAC CAG CGC ATC GTC GOC GTA TAC AGC
THR LEU LEU PRO PRO GLU LEU SER GLU THR PRO ASN ALA THR GLN
ACC CTG CTG CCC COG GAG CTG TCC GAG ACC CCC AAC GOC ACG CAG
280
PRO GLU LEU ALA PRO GLU ASP PRO GLU ASP SER ALA LEU LEU GLU
CCA GAA CTC GOC COG GAA GAC CCC GAG GAT TOG GCC CTC TTG GAG
Nerl
￿
295
ASP PRO VAL MY THR VAL ALA PRO GLN ILE PRO PRO ASN TRP HIS
GAC CCC GTG G33 ACG GTG GCG COG CAA ATC CCA CCA AAC TGG CAC
310
ILE PRO SER ILE GLN ASP ALA ALA THR OCT TYR HIS PRO PRO ALA
ATA COG TOG ATC CAO GAC GOC GCG ACG OCT TAC CAT CCC COG GOC
325
THR PRO ASN ASN MET GLY LEU ILE ALA GLY ALA VAL GLY GLY SER
ACC CCG AAC AAC ATG GM CTG ATC GCC GGC GOG GTG GOC OW AGT
340
LEU LEU ALA ALA LEU VAL ILE CYS GLY . ILE VAL TYR TRP MET ART
CTC CTG GCA GOC CTG GTC ATT TGC GGA ATT GTG TAC TOG ATG CGC
355
ARG ARG THR GLN LYS GLY PRO LYS ARG ILE ART LEU PRO HIS ILE
COC CGC ACT CAA AAA GGC CCA AAG OGC ATA COC CTC CCC CAC ATC
89
ARG GLU ASP ASP GLN PRO SER SER HIS CLN PRO LEU PHE -= ENO
CGG GAA GAC GAC CAG COG TT;C TOG CAC CAG CCC TTG TTT TAC TAG
ATA CCC CCC
250
LEU LYS ILE ALA GLY TRP HIS GLY PRO LYS ALA PRO TYR THR SER
TrG AAG ATC OCC G33 TOG CAC G3G CCC AAG GOC CCA TAC AGG AGC .....».»..... .... 265
Figure 9 .
￿
Nucleotide and predicted amino acid sequence of the -
HSV 1 ANG and ANG path regions encoding glycoprotein D . Rele-
vant restriction sites are labeled and three potential Winked glycosyla-
tion sites are marked by asterisks. The putative signal sequence is
marked with a line, the sequence difference between ANG and ANG
path is boxed, and the oligonucleotide primer used in Southern blot
analysis is indicated by the dark underline.
genotypically. DNA sequencing analysis of the ANG and
ANG path 1.4-kb HindlII/NruI fragments reveals a single
base pair difference. Analysis of this difference predicts that
ANG encodes alanine (GCC codon) at amino acid position
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Table 4 .
￿
Median Lethal Dosages (PFU/LDso) ofHSV-1 ANG,
ANG Path, and ANG Path 1.0 kb HindIII--NarI Fragment Rescued
Viruses after Rear Footpad Inoculation
Mice were inoculated with serial decimal dilutions of virus stock on
scarified rear footpads, and deaths from encephalomyelitis were scored
over a period of 21 d after inoculation . PFU/LCso ratios were calcu-
lated as described in Materials and Methods .
number 84 in the mature protein and ANG path encodes
glycine (GGC codon) at this same site (Fig. 9) .
Phenotypic analysis (Table 4) ofplaque-purified viruses re-
covered from the brains of mice killed by infection with virus
generated byANG DNA co-transfection with the ANG path
HindIII-NarI fragment indicates these agents are lethal for
mice following footpad inoculation . These agents (33LB1,
Figure 10 .
￿
Duplicate Southern blots of BamHI generated fragments
of ANG path, ANG, and three neuroinvasive viruses 33LB1, 33LC2,
and 3901D derived from co-transfections ofANG DNA with the 1.0-
kb ANG path HindIII/NarI fragment that comprises gD. These blots
were hybridized with 3 2P end-labeled oligonucleotide primer
5'CGCGGGGGCTCCGAAGAC3' which is predicted to be specific for
ANG path gD, and washed at 60°C or 65°C. Note that the probe re-
mained hybridized to ANG BamHI j fragment at 60°C but is removed
at 65°C . The probe remained hybridized to the BamHI j fragment de-
rived from ANG path and viruses 33LB1, 33LC2, and 3901D at both
temperatures. Neuroinvasive viruses are shown (NI+) .
Virus Exp . 1 Exp . 2 Exp . 3
ANG >1.15 x 108 >1.10 x 108 >1.09 x 108
ANG path 5.03 x 104 1.01 x 104 4.51 x 105
33LB1 7.08 x 105 2.49 x 106
33LC2 1.95 x 106 3.06 x 106
3901D 2.53 x 108 8.27 x 10 133LC2, and 3901D) demonstrate LDsos that range from 106
to 108 PFU. The genotypes of these agents were established
by stringent Southern hybridization. An oligodeoxynucleo-
tide probepredicted to be specific for the ANG path gD gene
(see legend to Fig. 10) was synthesized and then hybridized
to Southern blotted DNA derived from the various isolates.
Under appropriate hybridization stringency (Fig. 10, 65°C),
this probe can distinguish the gD-encoding ANG path BamHI
j fragment from ANG BamHI j fragment. By comparison,
the probe reveals no difference under reduced hybridization
stringency (Fig. 10, 60°C). Neuroinvasive agents recovered
from the brains of mice killed by infection with virus gen-
erated by ANG DNA co-transfection with the ANG path
HindIII/NarI fragment (33LB1, 33LC2, and 3901D) hy-
bridize to the probe similar to ANG path. The simplest in-
terpretation of these results is that these neuroinvasive agents
possess the same coding sequence as the ANG path gD gene.
Taken together, these results indicate that the defect in ANG
maps to nucleotide number 138,744 in the HSV1 sequence
(18, 19) and amino acid position 84 in glycoprotein D. This
predicts that an alanine in the ANG gD protein becomes gly-
cine in the ANG path gD protein.
Discussion
We have employed HSV1 ANG (4, 5), a strain that does
not cause lethal neurologic disease in mice following infec-
tion on rear footpads, and ANG path, a fully lethal brain-
passaged derivative of ANG, to show that this phenotypic
difference is related to a gene that specifically effects virus
entrance into the nervous system. Marker rescue experiments
utilizing cloned ANG path genes to confer neuroinvasive-
ness on ANG revealed that the gene that codes for gD is
responsible for this phenotypic difference. When ANG and
ANG path gD genes were sequenced, a single nucleotide differ-
ence predicted to change an alanine to glycine at amino acid
number 84 in the mature protein was noted. Using these
data, an oligodeoxynucleotide probe was prepared and em-
ployed in Southern blot analysis to demonstrate that neu-
roinvasive agents derived by marker rescue encode that base
change seen in the ANG path gD gene. From these results,
we conclude that HSV1 gD protein functions in vivo to effect
neuroinvasiveness, and that gD amino acid 84 is critical to
this process.
Before speculating on the potential mechanisms by which
a change in the primary amino acid sequence of gD could
alter neuroinvasiveness, it is important to summarize poten-
tially relevant properties of this protein. gD lies on the sur-
face ofthe virion and is anchored to the envelope at the COOH
terminus. The matureprotein is 369 amino acids long, it has
three potential Winked glycosylation sites, it is synthesized
both early and late during the viral replication cycle, and it
is translatedbetween short unique segment nucleotides 138,419
to 139,601 from an unspliced 2.8-kb polyadenylated transcript
(16-19). The predicted amino acid differencebetween the ANG
gD (position 84 alanine) and the ANG path gD (position
84 glycine) lies in a region that may be ot-helical. This sec-
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ondary structure is further predicted to lie in an exposed re-
verse turn domain that contains an N-linked glycosylated
amino acid (20, 21).
The predicted alteration in the primary amino acid se-
quence of ANG gD could potentially affect neuroinvasiveness
through two mechanisms. Since the ANG invasion is restricted
in the footpad because of reduced virus entry into the nervous
system and since gD protein performs an essential function
in virus replication to facilitate virion penetration into cells
(22, 23), it could be hypothesized that the alteration in the
ANG gD induces a structural change in the protein that may
lead to less efficient virion penetration into nerve terminals
in the footpad. Such a phenomenon could also be a property
ofnerve terminals between the peripheral and central nervous
systems. This change may be specific for nerve terminals as
opposed to neuron somas since ANG replicates efficiently in
the mouse brain where neuron somas are accessible to infec-
tion. The anatomic separation ofneuron soma and nerve ter-
minals in vivo, which is required to examine this hypothesis,
can be reproducedin vitro using Campenot chambers to cul-
ture dissociated spinal dorsal root ganglia (24). Such a system
may help to address the question of altered viral penetration
ofnerve terminals that may be caused by the predicted change
in the ANG gD protein.
The second mechanism that may be responsible for the
reduced entry of ANG into the nervous system relates to im-
munologic phenomena. Many investigations have shown that
gD protein stimulates productionofprotective antibody and
possibly cytotoxic T cells and is a major neutralizable herpes
antigen (25-30). Therefore, the ANG gD protein could be
more immunogenic or render the virion more susceptible to
restriction by adaptive immunity than the ANG path gD
protein. Mechanisms involving immune restriction of viral
invasion would predict that ANG and ANG path viruses dem-
onstrate similar capacity to induce lethal neurologic disease
in immune-suppressed mice following rear footpad inocu-
lation.
Finally, since replacement with ANG path gD gene se-
quences did not fully rescue ANG to the PFU/LDso ratio
demonstrated'by ANG path, it seems likely that another gene
in addition to the gD gene is involved in the reduced neu-
roinvasiveness phenotype of ANG. In this regard, since the
recombinants generated with the ANG path gD gene are
at least 10 timesless neuroinvasive than ANG path, a second
gene probably would function to a minor degree and might
function only in concert with ANG path gD gene. It is pos-
sible that the ANG path gD x ANG recombinant viruses
produced here (strains 33LB1, 33LC2, or 3901D) could be
used in marker rescue experiments to identify other genes
involved with the reduced neuroinvasiveness ofANG. As one
possibility, since HSV glycoproteins function together (31)
and since it is likely that gD protein interacts with other gly-
coproteins in the envelope, marker rescue with genes encoding
an ANG path glycoprotein and ANG path gD gene might
reveal the full potential neuroinvasiveness.
In summary, we have used biological and genetic methods
to show that HSV1 neuroinvasiveness is, in part, a functionofgD. Since this proteinis well characterized, continued in-
vestigation of this system is likely to lead to additional in-
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